Suppr超能文献

估算肾小球滤过率评估动脉粥样硬化性肾动脉狭窄患者肾动脉支架置入术后肾功能的有效性。

Validity of estimated glomerular filtration rates for assessment of renal function after renal artery stenting in patients with atherosclerotic renal artery stenosis.

机构信息

Department of Cardiovascular Medicine and Oakland University William Beaumont School of Medicine, Beaumont Health System, Royal Oak, Michigan.

Department of Cardiovascular Medicine and Oakland University William Beaumont School of Medicine, Beaumont Health System, Royal Oak, Michigan.

出版信息

JACC Cardiovasc Interv. 2014 May;7(5):543-9. doi: 10.1016/j.jcin.2013.11.021. Epub 2014 Apr 16.

Abstract

OBJECTIVES

The purpose of this study was to evaluate the validity of estimates of glomerular filtration rate (eGFR) for assessing serial changes in renal function after renal artery stenting.

BACKGROUND

eGFR are unreliable for assessing serial renal function in patients with atherosclerotic renal artery stenosis (RAS). eGFR have not been validated for assessment of serial renal function after renal artery stenting.

METHODS

Serum creatinine (SCr) and (125)I-iothalamate GFR (iGFR) were measured in RAS patients before and after renal artery stenting. eGFR were calculated from Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Cockcroft-Gault (CG) formulas. Using iGFR as the reference standard, the sensitivity, specificity, and area under the receiver-operating characteristic curve (AUC) were determined for MDRD, CKD-EPI, and CG for assessing changes in GFR before and after intervention.

RESULTS

Between 1998 and 2007, 84 patients underwent iGFR and eGFR before and after renal artery stenting. All eGFR demonstrated poor sensitivity and reliability for detecting ≥20% changes in iGFR, and poor agreement in the magnitude and direction of change in iGFR, before and after renal stenting.

CONCLUSIONS

In RAS patients, eGFR demonstrate poor sensitivity and reliability for detecting meaningful changes in iGFR after renal artery stenting. eGFR should be abandoned as primary endpoints in major clinical trials assessing the impact of renal revascularization on renal function.

摘要

目的

本研究旨在评估肾小球滤过率(eGFR)估计值评估肾动脉支架置入后肾功能连续变化的有效性。

背景

在动脉粥样硬化性肾动脉狭窄(RAS)患者中,eGFR 无法可靠地评估连续肾功能。eGFR 尚未经过验证,不能用于评估肾动脉支架置入后的连续肾功能。

方法

在肾动脉支架置入前后,测量 RAS 患者的血清肌酐(SCr)和(125)I-碘酞酸盐肾小球滤过率(iGFR)。使用改良肾脏病饮食研究(MDRD)、慢性肾脏病流行病学合作研究(CKD-EPI)和 Cockcroft-Gault(CG)公式计算 eGFR。使用 iGFR 作为参考标准,确定 MDRD、CKD-EPI 和 CG 在评估干预前后 GFR 变化方面的敏感性、特异性和受试者工作特征曲线下面积(AUC)。

结果

1998 年至 2007 年间,84 例患者接受了 iGFR 和 eGFR 检查,包括肾动脉支架置入前后。所有 eGFR 在检测 iGFR 变化≥20%方面的敏感性和可靠性均较差,且在肾支架置入前后,iGFR 变化的幅度和方向的一致性较差。

结论

在 RAS 患者中,eGFR 对检测肾动脉支架置入后 iGFR 的有意义变化的敏感性和可靠性较差。在评估肾血管重建对肾功能影响的主要临床试验中,应放弃 eGFR 作为主要终点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验